How Common Is B12 Deficiency, Really?
The scale of this problem tends to surprise people. Vitamin B12 deficiency is common and occurs worldwide. In the US and UK, around six percent of the general population have the deficiency; in those over the age of sixty, around twenty percent are deficient.
Vitamin B12 deficiency with the classic hematologic and neurologic signs and symptoms is uncommon. However, low or marginal vitamin B12 status without these symptoms is much more common, at up to forty percent in Western populations, especially in those with low intakes of vitamin B12-rich foods.
Global analyses from Europe, North America, and Asia report similar population-level patterns, where prevalence ranges from five to twenty percent depending on age, diet, and socioeconomic status. In short, this is not a rare edge case. It’s a widespread, frequently missed nutritional condition.
What B12 Actually Does in the Brain
Vitamin B12 serves as a cofactor for two critical enzymatic processes: methionine synthase, which facilitates the conversion of homocysteine to methionine – a reaction integral to DNA synthesis and epigenetic regulation – and methylmalonyl-CoA mutase, which catalyzes a key step in mitochondrial energy metabolism.
These biochemical roles underpin its necessity for neuronal integrity, myelination, and neurotransmitter synthesis, rendering vitamin B12 deficiency a potent disruptor of neurological homeostasis.
Vitamin B12 influences the synthesis of serotonin, norepinephrine, and dopamine. This suggests that, in addition to structural consequences of vitamin B12 deficiency, functional effects on neurotransmitter synthesis that may be relevant to mental status changes may also occur. In other words, the fogginess isn’t imagined. There’s real neurochemistry behind it.
The Myelin Connection: Why Your Nerves Go Quiet
In the nervous system, vitamin B12 helps produce a substance called myelin that shields the nerves and helps them transmit sensations. Without sufficient myelin, nerves are more prone to damage.
Myelin forms the protective sheath surrounding nerve fibres, enabling rapid electrical signal transmission. When B12 is deficient, demyelination occurs, particularly affecting the spinal cord’s posterior columns and lateral corticospinal tracts.
Neurological damage may begin before haematological changes appear, and prolonged deficiency can result in irreversible structural changes to nerve tissue, emphasising the importance of early detection and treatment. This is the part that catches many people off guard: the nerves can already be under stress before any blood test raises a flag.
The Homocysteine Problem: Brain Damage You Can’t Feel Yet
Elevated homocysteine levels, resulting from B12 deficiency, contribute to oxidative stress, vascular dysfunction, and neuroinflammation, accelerating brain atrophy in regions like the hippocampus and prefrontal cortex.
MRI studies confirm that individuals with elevated homocysteine levels exhibit faster hippocampal atrophy and increased white matter lesions. The hippocampus is the brain’s memory hub, so when it’s being quietly eroded, the effects show up as exactly the kind of slippery, hard-to-pin-down forgetfulness that people describe as brain fog.
Elevated methylmalonic acid and serum homocysteine levels are markers of vitamin B12 deficiency, and elevated homocysteine is also often associated with Alzheimer’s disease and stroke. These aren’t distant risks. They’re downstream consequences of a deficiency that may have been present for years.
New Research: “Normal” Levels May Not Be Enough
A study led by UC San Francisco researchers found that older, healthy volunteers with lower concentrations of B12, but still in the normal range, showed signs of neurological and cognitive deficiency.
These levels were associated with more damage to the brain’s white matter – the nerve fibres that enable communication between areas of the brain – and test scores associated with slower cognitive and visual processing speeds.
In the UCSF 2025 study, researchers found that total B12 wasn’t predictive of white matter lesion volume. What mattered was the level of holo-transcobalamin, the active form of B12 delivered to cells. Lower holo-TC was associated with a higher burden of these white matter lesions. This is a significant shift in how the medical community may need to think about testing and thresholds.
Who Is Most at Risk?
Studies indicate that ten to fifteen percent of people over sixty years old suffer from B12 deficiency, primarily due to age-related gastric atrophy, which reduces stomach acid production needed to release B12 from food.
Studies have consistently shown that vegetarians and vegans exhibit lower serum B12 levels and a higher prevalence of deficiency-related complications such as megaloblastic anemia, cognitive decline, and peripheral neuropathy.
Long-term use of certain medications, such as proton pump inhibitors and metformin, can impair B12 absorption, increasing the risk of deficiency. This last group often goes unrecognized – people managing diabetes or acid reflux may not realize their prescriptions are quietly depleting a vitamin their brain depends on.
Symptoms Beyond the Fog: The Full Picture
In moderate deficiencies, feeling tired, feeling faint, mouth ulcers, rapid breathing, upset stomach, pallor, hair loss, decreased ability to think, joint pain, and the beginning of neurological symptoms – including abnormal sensations such as numbness and tingling – may occur.
Problems are more common in the nerves in the hands and feet, known as peripheral nerves. Peripheral nerve damage may lead to tingling in these parts of the body. Over time, peripheral nerve damage can lead to movement problems.
Mental health conditions including depression, mood disorders, and psychosis are also associated with B12 deficiency. The range is striking. What starts as mild cognitive sluggishness can gradually shift into something that looks like a mood disorder or early neurological disease if the underlying deficiency stays unaddressed.
Why the Standard Blood Test Can Miss It
An isolated serum vitamin B12 level has poor sensitivity and specificity for reliably detecting the deficiency; it can be falsely low in some individuals, and falsely normal or high in deficient individuals.
The most sensitive marker of vitamin B12 status is a vitamin B12-associated metabolite called methylmalonic acid, and serum levels of this metabolite can be used to confirm a diagnosis of vitamin B12 deficiency if a patient’s serum vitamin B12 level falls in a borderline range.
Serum B12 alone may not fully capture intracellular cobalamin status. Incorporating functional biomarkers such as methylmalonic acid or holotranscobalamin could improve diagnostic specificity, particularly for individuals in the borderline range. Asking for these additional markers when you suspect a deficiency is a reasonable and evidence-backed step.
The Reversibility Window: Timing Matters
Early diagnosis and treatment are crucial in order to prevent irreversible damage to the nervous system. This is one of the most important practical points in this whole discussion.
The cord changes caused by B12 deficiency are initially reversible, and as the vitamin B12 deficiency goes untreated for a longer time, the changes become more and more irreversible and the responsiveness to treatment decreases.
Low serum vitamin B12 levels are associated with neurodegenerative disease and cognitive impairment. There is a small subset of dementias that are reversible with vitamin B12 therapy, and this treatment is inexpensive and safe. That last detail is worth pausing on. Reversible dementia. For a condition treatable with a common, affordable supplement.
Treatment Options: What the Evidence Supports
In cases involving gastrointestinal absorption barriers, intramuscular B12 injections are recommended as an effective management strategy to bypass absorption barriers and restore adequate levels.
Most people with serious deficiency are immediately given injections of vitamin B12, which are continued indefinitely to prevent symptoms from recurring. Large doses of vitamin B12 taken by mouth can be used if vitamin B12 deficiency is mild and symptoms of nerve damage have not developed.
Clinicians should consider supplementation in older patients with neurological symptoms even if their levels are within normal limits. This represents a meaningful shift from earlier clinical thinking, and reflects what newer research on active B12 forms is revealing about subclinical deficiency.
Conclusion
Brain fog is one of those symptoms that medicine often struggles to fully explain – it’s real, it’s disruptive, and it rarely fits neatly into a standard diagnostic box. Emerging evidence suggests that even marginal deficiencies, previously deemed subclinical, may contribute to subtle neurocognitive dysfunction, raising concerns about long-term public health implications in an era of increasing dietary restrictions and aging demographics.
This isn’t about dismissing other causes of cognitive fatigue. It’s about making sure a treatable, testable deficiency isn’t quietly being overlooked. Vitamin B12 insufficiency may be a preventable cause of cognitive decline, and that alone makes it worth a proper conversation with your doctor.
If the fog has been persistent, the tingling unexplained, and the fatigue disproportionate to your lifestyle, a full B12 workup – not just a serum level, but functional markers too – is a reasonable and sensible next step. Sometimes the most consequential discoveries are also the simplest ones.
